Progyny, Inc. (NASDAQ:PGNY) Expected to Earn FY2025 Earnings of $0.62 Per Share

Progyny, Inc. (NASDAQ:PGNY) – Leerink Partnrs cut their FY2025 earnings per share estimates for Progyny in a report issued on Wednesday, September 18th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $0.62 per share for the year, down from their previous forecast of $0.86. Leerink Partnrs currently has a “Hold” rating on the stock. The consensus estimate for Progyny’s current full-year earnings is $0.64 per share. Leerink Partnrs also issued estimates for Progyny’s FY2027 earnings at $1.41 EPS.

PGNY has been the topic of several other reports. Truist Financial lowered their target price on shares of Progyny from $33.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday. Cantor Fitzgerald lowered their price objective on Progyny from $37.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday. Canaccord Genuity Group cut Progyny from a “buy” rating to a “hold” rating and reduced their target price for the stock from $37.00 to $24.00 in a research report on Wednesday, August 7th. JMP Securities cut Progyny from an “outperform” rating to a “market perform” rating in a report on Thursday. Finally, Leerink Partners dropped their price target on Progyny from $25.00 to $21.00 and set a “market perform” rating for the company in a research report on Thursday. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Progyny presently has an average rating of “Hold” and a consensus price target of $27.73.

Progyny Trading Up 1.0 %

PGNY stock opened at $16.62 on Monday. The firm has a 50 day moving average of $24.08 and a 200-day moving average of $28.57. The firm has a market capitalization of $1.50 billion, a P/E ratio of 27.25, a price-to-earnings-growth ratio of 1.97 and a beta of 1.45. Progyny has a 12 month low of $13.93 and a 12 month high of $42.08.

Progyny (NASDAQ:PGNY) last issued its earnings results on Tuesday, August 6th. The company reported $0.17 EPS for the quarter, hitting the consensus estimate of $0.17. The business had revenue of $304.09 million during the quarter, compared to the consensus estimate of $305.32 million. Progyny had a return on equity of 11.97% and a net margin of 5.54%. The firm’s revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.15 EPS.

Insiders Place Their Bets

In other Progyny news, Director Cheryl Scott sold 1,462 shares of the stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of $28.39, for a total transaction of $41,506.18. Following the transaction, the director now directly owns 10,098 shares in the company, valued at $286,682.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, President Michael E. Sturmer sold 9,030 shares of the firm’s stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $30.00, for a total transaction of $270,900.00. Following the transaction, the president now directly owns 362,583 shares in the company, valued at approximately $10,877,490. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Cheryl Scott sold 1,462 shares of the business’s stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of $28.39, for a total value of $41,506.18. Following the completion of the sale, the director now owns 10,098 shares of the company’s stock, valued at approximately $286,682.22. The disclosure for this sale can be found here. 12.30% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Quarry LP boosted its position in Progyny by 1,900.0% during the 2nd quarter. Quarry LP now owns 880 shares of the company’s stock valued at $25,000 after buying an additional 836 shares during the period. TFC Financial Management Inc. bought a new position in shares of Progyny during the first quarter valued at about $42,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Progyny during the second quarter worth about $44,000. Financial Management Professionals Inc. bought a new stake in shares of Progyny in the first quarter worth about $52,000. Finally, Cambridge Trust Co. purchased a new position in Progyny during the 1st quarter valued at about $95,000. 94.93% of the stock is owned by hedge funds and other institutional investors.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.